Deutsch English Français

Contact

EP1345627

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1345627

EP1345627 - TARGETED MODIFICATION OF INTRACELLULAR COMPOUNDS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 25.11.2011 Database last updated on 02.11.2024
Most recent event Tooltip	25.11.2011	Application deemed to be withdrawn	published on 28.12.2011 [2011/52]
Applicant(s)	For all designated states CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 3, rue Michel-Ange 75794 Paris Cedex 16 / FR
	For all designated states THE MASSACHUSETTS GENERAL HOSPITAL 55 Fruit Street Boston Massachusetts 02114 / US
	For all designated states Molecular Sciences Institute 2168 Shattuck Avenue Berkeley, CA 94704 / US
	[N/P]
Former [2003/39]	For all designated states Centre National De La Recherche Scientifique 3, rue Michel-Ange 75794 Paris Cedex 16 / FR
	For all designated states THE MASSACHUSETTS GENERAL HOSPITAL 55 Fruit Street Boston Massachusetts 02114 / US
	For all designated states Molecular Sciences Institute 2168 Shattuck Avenue Berkeley, CA 94704 / US
Inventor(s)	01 / COLAS, Pierre 8, Rue de l'Archinière F-69370 Saint Didier Mont d'Or / FR
	02 / BRENT, Roger 1106 Miller Avenue Berkeley, CA 94708 / US
	03 / COHEN, Barak, A. 5096 Waterman Avenue; Apartment A St Louis, MO 63108 / US
	04 / MONCORGE, Olivier 19, avenue Jean Jaurès F-69007 Lyon
	[2006/20]
Former [2003/39]	01 / COLAS, Pierre 8, Rue de l'Archinière F-69370 Saint Didier Mont d'Or / FR
	02 / BRENT, Roger 1106 Miller Avenue Berkeley, CA 94708 / US
	03 / COHEN, Barak, A. 9 Magazine St., Apt. B3 Cambridge, MA 02139 / US
Representative(s)	Almond-Martin, Carol, et al Ernest Gutmann - Yves Plasseraud S.A.S. 3, rue Auber 75009 Paris / FR
	[N/P]
Former [2003/39]	Almond-Martin, Carol, et al Ernest Gutmann - Yves Plasseraud S.A. 3, rue Chauveau-Lagarde 75008 Paris / FR
Application number, filing date	01273076.8	13.11.2001
	[2003/39]
	WO2001EP14199
Priority number, date	EP20000403156	13.11.2000 Original published format: EP 00403156
	[2003/39]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO02055108
	Date:	18.07.2002
	Language:	EN
	[2002/29]
	Type:	A1 Application with search report
	No.:	EP1345627
	Date:	24.09.2003
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 18.07.2002 takes the place of the publication of the European patent application.
	[2003/39]
Search report(s)	International search report - published on:	EP	18.07.2002
Classification	IPC:	A61K47/48	[2003/39]
	CPC:	A61K47/6425 (EP,US); A61P1/02 (EP); A61P17/00 (EP); A61P21/00 (EP); A61P25/00 (EP); A61P3/00 (EP); (+) A61P31/04 (EP); A61P31/10 (EP); A61P31/12 (EP); A61P35/00 (EP); A61P37/02 (EP); A61P9/10 (EP) (-)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/39]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	GEZIELTE MODIFIKATION INTRAZELLULÄRER VERBINDUNGEN	[2003/39]
	English:	TARGETED MODIFICATION OF INTRACELLULAR COMPOUNDS	[2003/39]
	French:	MODIFICATION CIBLEE DE COMPOSES INTRACELLULAIRES	[2003/39]
Entry into regional phase	06.06.2003	National basic fee paid
	06.06.2003	Designation fee(s) paid
	06.06.2003	Examination fee paid
Examination procedure	13.06.2002	Request for preliminary examination filed International Preliminary Examining Authority: EP
	06.06.2003	Examination requested [2003/39]
	23.06.2006	Despatch of a communication from the examining division (Time limit: M06)
	19.04.2007	Reply to a communication from the examining division
	13.08.2007	Despatch of a communication from the examining division (Time limit: M06)
	25.02.2008	Reply to a communication from the examining division
	01.06.2011	Application deemed to be withdrawn, date of legal effect [2011/52]
	22.07.2011	Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2011/52]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 23.06.2006
Request for further processing for:	19.04.2007	Request for further processing filed
	19.04.2007	Full payment received (date of receipt of payment) Request granted
	11.05.2007	Decision despatched
Fees paid	Renewal fee
	28.11.2003	Renewal fee patent year 03
	26.11.2004	Renewal fee patent year 04
	12.10.2005	Renewal fee patent year 05
	12.10.2006	Renewal fee patent year 06
	15.10.2007	Renewal fee patent year 07
	26.03.2008	Renewal fee patent year 08
	25.11.2009	Renewal fee patent year 09
	Penalty fee
	Additional fee for renewal fee
	30.11.2010	10 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[X] - KOLONIN, MIKHAIL G. ET AL, "Targeting cyclin -dependent kinases in Drosophila with peptide aptamers", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (1998), 95(24), 14266-14271, XP002201318 [X] 1 * abstract * DOI: http://dx.doi.org/10.1073/pnas.95.24.14266
		[DX] - COLAS, PIERRE, "Combinatorial protein reagents to manipulate protein function", CURR. OPIN. CHEM. BIOL. (2000), 4(1), 54-59, XP000993058 [DX] 1-83 * abstract * DOI: http://dx.doi.org/10.1016/S1367-5931(99)00051-4
		[X] - MURPHY, ANNE M. ET AL, "Genetic selection of peptide aptamers that recognize and inhibi cyclin -dependent kinase 2. Identification of D-peptide ligands through mirror-image phage display", CHEMTRACTS (1997), 10(7), 527-532, XP001073705 [X] 1-83 * page 531, paragraph 3 *
		[DY] - COLAS, PIERRE ET AL, "The impact of two - hybrid and related methods on biotechnology", TRENDS BIOTECHNOL. (1998), 16(8), 355-363, XP002166742 [DY] 1-83 * abstract * DOI: http://dx.doi.org/10.1016/S0167-7799(98)01225-6
		[DY] - COLAS, PIERRE ET AL, "Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2", NATURE (LONDON) (1996), 380(6574), 548-50, XP002166743 [DY] 1-83 * the whole document * DOI: http://dx.doi.org/10.1038/380548a0
		[DY] - COHEN, BARAK A. ET AL, "An artificial cell-cycle inhibitor isolated from a combinatorial library", PROC. NATL. ACAD. SCI. U. S. A. (1998), 95(24), 14272-14277, XP002166744 [DY] 1-83 * abstract * DOI: http://dx.doi.org/10.1073/pnas.95.24.14272
		[PX] - COLAS, PIERRE ET AL, "Targeted modification and transportation of cellular proteins", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000), 97(25), 13720-13725, XP002201319 [PX] 1-83 * abstract * DOI: http://dx.doi.org/10.1073/pnas.97.25.13720
	Examination	WO0178785
		WO0247730

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p